Obesity is not strongly associated with increased risk for febrile neutropenia during levofloxacin prophylaxis in patients with hematological malignancies receiving intermediate-risk myelosuppressive chemotherapy. [electronic resource]
Producer: 20201201Description: 1301-1305 p. digitalISSN:- 1477-092X
- Aged
- Anti-Bacterial Agents -- therapeutic use
- Antibiotic Prophylaxis -- trends
- Antineoplastic Agents -- adverse effects
- Body Mass Index
- Cohort Studies
- Febrile Neutropenia -- chemically induced
- Female
- Hematologic Neoplasms -- drug therapy
- Humans
- Levofloxacin -- therapeutic use
- Male
- Middle Aged
- Obesity -- drug therapy
- Retrospective Studies
- Risk Factors
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.